Related Experiment Video
Updated: May 22, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Orbital aspergillosis: voriconazole - the new standard treatment?
Derek H Ohlstein1, Claudia Hooten, Javier Perez
1Neuro-Ophthalmology Service, Department of Ophthalmology, University of Florida, Gainesville, Fla., USA.
Background/Aim:
To describe a case of invasive orbital aspergillosis and evaluate treatments and outcomes.
Methods:
A case report and review of orbital aspergillosis treatment with voriconazole in the English language literature.
Conclusion:
Amphotericin B with debridement is the current standard of care for orbital aspergillosis; however, its prognosis is unfavorable. When compared to amphotericin B, voriconazole demonstrates a survival benefit, has less systemic toxicity, and is better tolerated by patients. While a prospective trial comparing amphotericin B to voriconazole in orbital aspergillosis is not feasible, there is evidence to support the use of voriconazole as primary therapy.
Related Concept Videos
Antifungal Agents
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Treatment Resistent Cancers
Treatment Resistant Cancers
Pharmaceutical Poisoning: Treatment Strategies